MaxPro Medical
MaxPro Medical
Paris is not only the cultural capital of the world but also a central hub for European healthcare innovation. Within the Île-de-France region, the demand for Point-of-Care Testing (POCT) solutions has surged by 15% annually. As the French healthcare system emphasizes the "Santé 2030" plan, there is a strategic shift from hospital-centric care to home-based chronic disease management. For a Cholesterol Meter Manufacturer & Exporter, the Paris market represents a sophisticated demographic that values CE-marked, high-accuracy devices that integrate seamlessly with digital health ecosystems.
Globally, the lipid profile testing market is expected to reach $1.5 billion by 2027. The rise in cardiovascular diseases (CVDs), coupled with an aging global population, has necessitated the development of multi-parameter monitors. Today’s industry is moving beyond simple "glucose-only" devices. The integration of Cholesterol, Triglycerides, HDL, and LDL into a single handheld unit—often referred to as a "mobile lab"—is the current gold standard. Our role as an exporter involves ensuring that these technologies meet the rigorous GDPR standards for data privacy in Europe and the high precision requirements of the IVDR (In Vitro Diagnostic Regulation).
Global Distributors
Production Facility
Certified Quality
Accuracy Rate
The next decade of cholesterol monitoring will be defined by three pillars: Miniaturization, Connectivity, and Information Gain. Information Gain refers to the additional diagnostic value provided by AI-driven analysis of raw lipid data. Our R&D focuses on:
Founded in 2009, Shenzhen MaxPro Medical Co., Ltd. is a leading manufacturer specializing in advanced medical devices and chronic disease monitoring solutions. With a strong commitment to innovation, quality, and customer satisfaction, we provide reliable healthcare technologies to over 500 healthcare institutions and distributors worldwide.
Our company operates a modern 20,000 sq ft manufacturing facility equipped with advanced production and testing systems. Certified under ISO 13485 quality management standards, all of our products comply with international medical regulations, with key products receiving FDA 510(k) clearance and CE certification.
Our Paris clients benefit from our rigorous 12-step quality assurance process, ensuring every meter exceeds clinical standards.
As a global Cholesterol Meter Manufacturer & Exporter, we don't just sell devices; we provide comprehensive healthcare solutions. Our macro-level strategies include:
Providing Parisian pharmacies with POCT kiosks that allow for rapid customer screening, driving foot traffic and improving public health outcomes.
Specialized monitoring kits for elderly care homes in the Île-de-France region, focusing on ease of use and automated data logging.
Custom branding and localized software development for large European medical distributors seeking unique market positioning.
A: Yes, all our devices are CE-certified and comply with the latest EU In Vitro Diagnostic Medical Device Regulation (IVDR), ensuring they meet the safety and performance standards required in France.
A: Our meters use advanced dry chemistry or electrochemical biosensing technologies. Every batch undergoes calibration against laboratory-grade reference equipment to ensure a high correlation with clinical lab results.
A: Our smart monitors support Bluetooth connectivity and HL7 protocol options, allowing for potential integration with EMR (Electronic Medical Record) systems used across the European Union.
A: For bulk orders, we typicaly offer air-freight options arriving at Charles de Gaulle (CDG) airport within 7-10 business days after production completion.
A: Information Gain is our proprietary approach where our devices provide more than just a number; they provide metabolic trend analysis and risk assessment, giving physicians more actionable data than traditional basic meters.
Ready to upgrade your diagnostic offerings in the Paris market?
Get a Personalized Quote for Your Region
